Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Phase 2b VESPER-3 study of PF-08653944 (MET-097i), which is an injectable GLP-1 receptor agonist. The trial met its primary endpoint and showed a statistically significant, placebo-adjusted weight loss of up to 12.3% at 28 weeks. Notably, patients continued to lose weight after transitioning from weekly to monthly dosing, with no plateau observed by the end of the 28 weeks. The study also confirmed a favorable safety and tolerability profile, consistent with the broader GLP-1 class, as gastrointestinal side effects were primarily mild to moderate. These results have reinforced Pfizer's confidence in pursuing higher maintenance doses for its upcoming clinical trials. Detailed findings from the study are scheduled to be presented at the American Diabetes Association's Scientific Sessions in June 2026. Piotr Kowalski/Shutterstock.com Following its acquisition of Metsera, Pfizer is accelerating an expansive obesity development program that includes over 20 planned or ongoing studies
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Trump administration to launch TrumpRx website for discounted drugs [Los Angeles Times (CA)]Los Angeles Times
- Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off [Yahoo! Finance Canada]Yahoo! Finance Canada
- ??????????????????? - ??????????????????2026-2035? [CNET News]CNET News
- ??????????????????????????: 2032????19?8813?????????? [CNET News]CNET News
- Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 2/3/26 - Form 8-K
- 2/2/26 - Form 4
- 1/16/26 - Form 4
- PFE's page on the SEC website